Literature DB >> 956360

Virological and serological studies of Venezuelan equine encephalomyelitis in humans.

G S Bowen, C H Calisher.   

Abstract

During the 1971 epidemic of Venezuelan equine encephalomyelitis (VEE) in south Texas, 203 suspect VEE cases were evaluated by the Center for Disease Control. Sixty-seven were confirmed as cases of VEE. Laboratory confirmation was accomplished by isolation of VEE virus from a serum specimen taken during the acute illness in 50 (75%) of the confirmed cases. Serological confirmation was obtained in 17 cases (25%). Virus isolations were most often obtained from sera collected during the first 3 days of illness. Peak serum virus titers (algebraic mean, 10(5-7) suckling mouse intracranial 50% lethal doses [SMICLD50] per ml) occurred on day 2 of illness. One-half of the sera from which virus was isolated contained at least 10(5) SMICLD50/ml, which has been shown to be sufficient to infect some vector mosquitoes. Blood from 13 virus-positive VEE cases was obtained 1 and 11 months after illness. Hemagglutination-inhibiting, complement-fixing, and neutralizing antibodies were formed by all 13 patients 1 month after illness. Hemagglutination-inhibiting antibody titers were essentially unchanged 11 months after illness. Complement-fixing antibody was undetectable 11 months after illness in 23% of cases and was detectable at dilutions of 1:8 or 1:6 in 77%. Neutralizing antibody (measured by log neutralization index) was not detectable 1 year after illness in one person (8%); titers had declined from 1.0 to 2.0 in 46%, were unchanged in 39%, and were not tested in one person (8%). No evidence of intrafamilial spread of VEE virus was obtained in either of two illness and antibody surveys. A randomized household illness and antibody survey of 681 Port Isabel residents revealed an inapparent infection ratio of 1:11 and an overall antibody prevalence of 3.2%.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956360      PMCID: PMC274383          DOI: 10.1128/jcm.4.1.22-27.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  SEROLOGIC EPIDEMIOLOGY OF WESTERN EQUINE AND ST. LOUIS ENCEPHALITIS VIRUS INFECTION IN CALIFORNIA. II. ANALYSIS OF INAPPARENT INFECTIONS IN RESIDENTS OF AN ENDEMIC AREA.

Authors:  J E FROESCHLE; W C REEVES
Journal:  Am J Epidemiol       Date:  1965-01       Impact factor: 4.897

2.  INVESTIGATIONS DURING VENEZUELAN EQUINE ENCEPHALITIS OUTBREAKS IN VENEZUELA--1962-1964.

Authors:  R F SELLERS; G H BERGOLD; O M SUAREZ; A MORALES
Journal:  Am J Trop Med Hyg       Date:  1965-05       Impact factor: 2.345

3.  An epidemic of St. Louis encephalitis in Cameron County, Texas, in 1957.

Authors:  J A BRODY; G BROWNING
Journal:  Am J Trop Med Hyg       Date:  1960-07       Impact factor: 2.345

4.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

5.  Serologic studies of encephalitis in Japan. I. Hemagglutination-inhibiting, complement-fixing, and neutralizing antibody following overt Japanese B encephalitis.

Authors:  C M SOUTHAM
Journal:  J Infect Dis       Date:  1956 Sep-Oct       Impact factor: 5.226

6.  Inapparent infection with western equine encephalitis virus: epidemiologic observations.

Authors:  G D LAVECK; J F WINN; S F WELCH
Journal:  Am J Public Health Nations Health       Date:  1955-11

7.  Human epidemic in Colombia caused by the Venezuelan equine encephalomyelitis virus.

Authors:  C SANMARTIN-BARBERI; H GROOT; E OSORNO-MESA
Journal:  Am J Trop Med Hyg       Date:  1954-03       Impact factor: 2.345

8.  Experimental infection of horses with three strains of Venezuelan equine encephalomyelitis virus. II. Experimental vector studies.

Authors:  W D Sudia; V F Newhouse; B E Henderson
Journal:  Am J Epidemiol       Date:  1971-03       Impact factor: 4.897

Review 9.  Rural epidemic encephalitis in Venezuela caused by a group A arbovirus (VEE).

Authors:  A L Rossi
Journal:  Prog Med Virol       Date:  1967

10.  Venezuelan equine encephalitis epidemic in Texas, 1971.

Authors:  R B Zehmer; P B Dean; W D Sudia; C H Calisher; G E Sather; R L Parker
Journal:  Health Serv Rep       Date:  1974 May-Jun
View more
  17 in total

Review 1.  Aptamers isolated against mosquito-borne pathogens.

Authors:  Tholasi Nadhan Navien; Tzi Shien Yeoh; Andrew Anna; Thean-Hock Tang; Marimuthu Citartan
Journal:  World J Microbiol Biotechnol       Date:  2021-07-09       Impact factor: 3.312

2.  Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella.

Authors:  Patricia V Aguilar; Jose G Estrada-Franco; Roberto Navarro-Lopez; Cristina Ferro; Andrew D Haddow; Scott C Weaver
Journal:  Future Virol       Date:  2011       Impact factor: 1.831

3.  Repeated emergence of epidemic/epizootic Venezuelan equine encephalitis from a single genotype of enzootic subtype ID virus.

Authors:  A M Powers; M S Oberste; A C Brault; R Rico-Hesse; S M Schmura; J F Smith; W Kang; W P Sweeney; S C Weaver
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Comparison of Aerosol- and Percutaneous-acquired Venezuelan Equine Encephalitis in Humans and Nonhuman Primates for Suitability in Predicting Clinical Efficacy under the Animal Rule.

Authors:  Janice M Rusnak; Lesley C Dupuy; Nancy A Niemuth; Andrew M Glenn; Lucy A Ward
Journal:  Comp Med       Date:  2018-10-03       Impact factor: 0.982

5.  The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

6.  Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model.

Authors:  Christopher H Logue; Christopher F Bosio; Thomas Welte; Kimberley M Keene; Jeremy P Ledermann; Aaron Phillips; Brian J Sheahan; Dennis J Pierro; Nicole Marlenee; Aaron C Brault; Catharine M Bosio; Amber J Singh; Ann M Powers; Ken E Olson
Journal:  J Gen Virol       Date:  2009-04-29       Impact factor: 3.891

Review 7.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

Review 8.  North American encephalitic arboviruses.

Authors:  Larry E Davis; J David Beckham; Kenneth L Tyler
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

9.  Venezuelan equine encephalitis--Colombia, 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-10-06       Impact factor: 17.586

10.  Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia.

Authors:  Cristina Ferro; Jorge Boshell; Abelardo C Moncayo; Marta Gonzalez; Marta L Ahumada; Wenli Kang; Scott C Weaver
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.